share_log

PSQ Holdings | 8-K: Current report

SEC ·  Jul 8 16:18

Summary by Moomoo AI

PSQ Holdings announced on July 8, 2024, that its subsidiary, Credova SPV I, LLC, has executed Amendment No. 5 to its $10 million revolving credit facility on July 1, 2024. The amendment extends the Funding Termination Date by one year to June 30, 2025, and modifies several key terms.The changes include increasing the advance rate on Eligible Receivables to 89% for loans less than 61 days past due, standardizing the Delinquency and Liquidated Receivables Percentage Triggering Events, and adjusting Concentration Limits. The interest rate on Aggregate Outstanding Advances has been modified to 14.5% per annum, and a Non-use Fee has been added for portions exceeding $5 million.This amendment follows PSQ Holdings' merger with Credova Holdings, Inc., consummated on March 13, 2024, where the company assumed the credit facility. The changes aim to provide enhanced financial flexibility and support for the company's operations post-merger.
PSQ Holdings announced on July 8, 2024, that its subsidiary, Credova SPV I, LLC, has executed Amendment No. 5 to its $10 million revolving credit facility on July 1, 2024. The amendment extends the Funding Termination Date by one year to June 30, 2025, and modifies several key terms.The changes include increasing the advance rate on Eligible Receivables to 89% for loans less than 61 days past due, standardizing the Delinquency and Liquidated Receivables Percentage Triggering Events, and adjusting Concentration Limits. The interest rate on Aggregate Outstanding Advances has been modified to 14.5% per annum, and a Non-use Fee has been added for portions exceeding $5 million.This amendment follows PSQ Holdings' merger with Credova Holdings, Inc., consummated on March 13, 2024, where the company assumed the credit facility. The changes aim to provide enhanced financial flexibility and support for the company's operations post-merger.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more